Preventing autoimmune diabetes in genetically susceptible people
Open Access Government · 2022
DOI: 10.56367/oag-036-10090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Access Government, 2022. Verfasst von Peter A. Bretscher.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Preventing autoimmune diabetes in genetically susceptible people Here, Professor Emeritus Peter Bretscher explores if we can now envisage antigen-specific therapies to prevent and treat organ-specific autoimmune diseases, such as autoimmune diabetes? He sketches for clarity the framework employed, as justified elsewhere. Most anti-self lymphocytes are eliminated as generated in primary lymphoid organs by the mechanism of central tolerance. A minority of self-antigens, such as insulin, are insufficiently present to cause complete central tolerance. Mature lymphocytes specific for peripheral self-antigens, and others specific for foreign antigens, are found in the periphery.
Zitieren
APA
Bretscher, P. A. (2022). Preventing autoimmune diabetes in genetically susceptible people. Open Access Government. https://doi.org/10.56367/oag-036-10090
Vancouver
Bretscher PA. Preventing autoimmune diabetes in genetically susceptible people. Open Access Government. 2022. doi:10.56367/oag-036-10090
BibTeX
@article{Bretscher2022,
author = {Bretscher, Peter A.},
title = {Preventing autoimmune diabetes in genetically susceptible people},
journal = {Open Access Government},
year = {2022},
doi = {10.56367/oag-036-10090}
}
EUVIMED